Financial statements Bioventures Institute

Balance sheet of Bioventures Institute

Company age:
Age:
15 y. 9 m. 28 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of BIOVENTURES INSTITUTE

Year
2018
2019
2020
2021
2022
Total assets 505 217,49 342 035,05 366 365,58 550 457,50 510 569,77
A. Fixed assets 258 841,43 258 711,86 258 748,86 437 231,22 394 580,58
B. Current assets 246 376,06 83 323,19 107 616,72 113 226,28 115 989,19
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00
Total liabilities 505 217,49 342 035,05 366 365,58 550 457,50 510 569,77
A. Equity 448 608,25 285 656,49 323 927,58 182 886,48 27 865,23
B. Liabilities and provisions for liabilities 56 609,24 56 378,56 42 438,00 367 571,02 482 704,54
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 55 997,24 55 766,56 20 989,77 366 334,02 482 704,54
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.